Effect of Probiotics on Colonic Microbiota and Metabolite Production in Cystic Fibrosis: A Comparative In Vitro Study

Overview

Journal Nutrients

Date 2023 Sep 9

PMID 37686878

Authors

Andrea Asensio-Grau

Joaquim Calvo-Lerma

Miguel Ferriz-Jordan

Jorge Garcia-Hernandez

Ana Heredia

Ana Andres

Affiliations

Soon will be listed here.

Abstract

Cystic Fibrosis-related gut dysbiosis (CFRGD) has become a recognised complication in children with this condition, and current evidence remains insufficient to guide the selection of probiotic strains for supplementation treatments. The aim of this study was to characterise the effect of three probiotic strains on CFRGD by means of a dynamic in vitro simulation of the colonic fermentation (SHIME). The configuration of the system included three bioreactors colonised with the faecal inoculum of a child with cystic fibrosis. For 20 days, each bioreactor was supplied daily with either (ATCC 53103 TM), (DSM 17938) or (DSM 22266). The baseline microbiota was characterised by a high abundance of , and genera. After 20 days of supplementation, and reduced significantly, and the three strains led to increased and and decreased , with some of these changes being maintained 10 days after ceasing supplementation. The metabolic activity remained unaltered in terms of short-chain fatty acids, but branched-chain fatty acids showed a significant decrease, especially with . Additionally, ammonia decreased at 20 days of supplementation, and lactate continuously increased with the three strains. The effects on colonic microbiota of , or were established, including increased beneficial bacteria, such as , and beneficial metabolites such as lactate; and on the other hand, a reduction in pathogenic genera, including or and branched-chain fatty acids, overall supported their use as probiotics in the context of CFRGD.

Citing Articles

Diagnosis and Management of Gastrointestinal Manifestations in Children with Cystic Fibrosis.

Anton-Paduraru D, Murgu A, Bozomitu L, Mindru D, Iliescu Halitchi C, Trofin F Diagnostics (Basel). 2024; 14(2).

PMID: 38275475 PMC: 10814426. DOI: 10.3390/diagnostics14020228.

Effect of beta-glucan supplementation on cystic fibrosis colonic microbiota: an in vitro study.

Asensio-Grau A, Heredia A, Garcia-Hernandez J, Cabrera-Rubio R, Masip E, Ribes-Koninckx C Pediatr Res. 2023; 95(6):1519-1527.

PMID: 38092964 DOI: 10.1038/s41390-023-02944-0.

References

Marsh R, Gavillet H, Hanson L, Ng C, Mitchell-Whyte M, Major G . Intestinal function and transit associate with gut microbiota dysbiosis in cystic fibrosis. J Cyst Fibros. 2021; 21(3):506-513. DOI: 10.1016/j.jcf.2021.11.014. View

Ray K, Santee C, McCauley K, Panzer A, Lynch S . Gut Bifidobacteria enrichment following oral Lactobacillus-supplementation is associated with clinical improvements in children with cystic fibrosis. BMC Pulm Med. 2022; 22(1):287. PMC: 9330662. DOI: 10.1186/s12890-022-02078-9. View

Calvo-Lerma J, Boon M, Hulst J, Colombo C, Asseiceira I, Garriga M . Change in Nutrient and Dietary Intake in European Children with Cystic Fibrosis after a 6-Month Intervention with a Self-Management mHealth Tool. Nutrients. 2021; 13(6). PMC: 8229611. DOI: 10.3390/nu13061801. View

Kristensen M, Prevaes S, Kalkman G, Tramper-Stranders G, Hasrat R, de Winter-de Groot K . Development of the gut microbiota in early life: The impact of cystic fibrosis and antibiotic treatment. J Cyst Fibros. 2020; 19(4):553-561. DOI: 10.1016/j.jcf.2020.04.007. View

Manor O, Levy R, Pope C, Hayden H, Brittnacher M, Carr R . Metagenomic evidence for taxonomic dysbiosis and functional imbalance in the gastrointestinal tracts of children with cystic fibrosis. Sci Rep. 2016; 6:22493. PMC: 4778032. DOI: 10.1038/srep22493. View

Coffey M, Nielsen S, Wemheuer B, Kaakoush N, Garg M, Needham B . Gut Microbiota in Children With Cystic Fibrosis: A Taxonomic and Functional Dysbiosis. Sci Rep. 2019; 9(1):18593. PMC: 6901462. DOI: 10.1038/s41598-019-55028-7. View

Hoffman L, Pope C, Hayden H, Heltshe S, Levy R, McNamara S . Escherichia coli dysbiosis correlates with gastrointestinal dysfunction in children with cystic fibrosis. Clin Infect Dis. 2013; 58(3):396-9. PMC: 3890337. DOI: 10.1093/cid/cit715. View

Albedewi H, Bindayel I, Albarrag A, Banjar H . Correlation of Gut Microbiota, Vitamin D Status, and Pulmonary Function Tests in Children With Cystic Fibrosis. Front Nutr. 2022; 9:884104. PMC: 9218790. DOI: 10.3389/fnut.2022.884104. View

Tett A, Pasolli E, Masetti G, Ercolini D, Segata N . Prevotella diversity, niches and interactions with the human host. Nat Rev Microbiol. 2021; 19(9):585-599. PMC: 11290707. DOI: 10.1038/s41579-021-00559-y. View

10.

Duncan S, Hold G, Harmsen H, Stewart C, Flint H . Growth requirements and fermentation products of Fusobacterium prausnitzii, and a proposal to reclassify it as Faecalibacterium prausnitzii gen. nov., comb. nov. Int J Syst Evol Microbiol. 2003; 52(Pt 6):2141-2146. DOI: 10.1099/00207713-52-6-2141. View

11.

van Dorst J, Tam R, Ooi C . What Do We Know about the Microbiome in Cystic Fibrosis? Is There a Role for Probiotics and Prebiotics?. Nutrients. 2022; 14(3). PMC: 8840103. DOI: 10.3390/nu14030480. View

12.

Windey K, De Preter V, Verbeke K . Relevance of protein fermentation to gut health. Mol Nutr Food Res. 2011; 56(1):184-96. DOI: 10.1002/mnfr.201100542. View

13.

Klindworth A, Pruesse E, Schweer T, Peplies J, Quast C, Horn M . Evaluation of general 16S ribosomal RNA gene PCR primers for classical and next-generation sequencing-based diversity studies. Nucleic Acids Res. 2012; 41(1):e1. PMC: 3592464. DOI: 10.1093/nar/gks808. View

14.

Liu Y, Tian X, He B, Hoang T, Taylor C, Blanchard E . DSM 17938 feeding of healthy newborn mice regulates immune responses while modulating gut microbiota and boosting beneficial metabolites. Am J Physiol Gastrointest Liver Physiol. 2019; 317(6):G824-G838. PMC: 6962498. DOI: 10.1152/ajpgi.00107.2019. View

15.

Murugesan S, Nirmalkar K, Hoyo-Vadillo C, Garcia-Espitia M, Ramirez-Sanchez D, Garcia-Mena J . Gut microbiome production of short-chain fatty acids and obesity in children. Eur J Clin Microbiol Infect Dis. 2017; 37(4):621-625. DOI: 10.1007/s10096-017-3143-0. View

16.

Rocha Faria Duque A, Demarqui F, Santoni M, Zanelli C, Adorno M, Milenkovic D . Effect of probiotic, prebiotic, and synbiotic on the gut microbiota of autistic children using an in vitro gut microbiome model. Food Res Int. 2021; 149:110657. DOI: 10.1016/j.foodres.2021.110657. View

17.

Schippa S, Iebba V, Santangelo F, Gagliardi A, De Biase R, Stamato A . Cystic fibrosis transmembrane conductance regulator (CFTR) allelic variants relate to shifts in faecal microbiota of cystic fibrosis patients. PLoS One. 2013; 8(4):e61176. PMC: 3629184. DOI: 10.1371/journal.pone.0061176. View

18.

Callahan B, McMurdie P, Rosen M, Han A, Johnson A, Holmes S . DADA2: High-resolution sample inference from Illumina amplicon data. Nat Methods. 2016; 13(7):581-3. PMC: 4927377. DOI: 10.1038/nmeth.3869. View

19.

Van den Abbeele P, Venema K, Van de Wiele T, Verstraete W, Possemiers S . Different human gut models reveal the distinct fermentation patterns of Arabinoxylan versus inulin. J Agric Food Chem. 2013; 61(41):9819-27. DOI: 10.1021/jf4021784. View

20.

Nielsen S, Needham B, Leach S, Day A, Jaffe A, Thomas T . Disrupted progression of the intestinal microbiota with age in children with cystic fibrosis. Sci Rep. 2016; 6:24857. PMC: 4855157. DOI: 10.1038/srep24857. View